“receptos” Archives

in
Entry Author Date Location
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
Celgene Touts Data From Early Study of Oral GI Drug 09/12/16 Boston
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug 09/09/15 Boston
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
West Coast Biotech Roundup: Receptos, ProNAi, Protagonist & More 07/16/15 San Diego
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
Protagonist Nabs $40M, Eyes 1st Trial Of Oral Peptide In Gut Disease 07/16/15 San Francisco
Celgene to Acquire San Diego’s Receptos for $7.2B in Cash 07/14/15 San Diego
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
West Coast Biotech Roundup: Burrill, Topol, Aduro, Receptos, & More 06/19/14 San Francisco
With Biotech IPO Outlet, San Diego Venture Funding at 15-Year Low 01/21/14 San Diego
San Diego Life Sciences Roundup: Isis, Receptos, Suneva, and More 01/17/14 San Diego
San Diego Life Sciences Roundup: Receptos, Auspex, Avelas, and More 01/10/14 San Diego
Insulin Pump Maker Tandem Diabetes Plans to Raise $100M Through IPO 10/08/13 San Diego
U.S. Venture Activity Remains Steady as IPOs Rise in Second Quarter 07/16/13 National
The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013 06/03/13 National
Receptos Obtains $72,800,000 New Round 05/10/13 San Diego
San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More 05/09/13 San Diego
San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts 05/06/13 San Diego
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
San Diego Life Sciences Roundup: Receptos, Vital Therapies, & More 02/23/12 San Diego
Receptos Receives $10,806,610 New Round 02/22/12 San Diego
See You Tonight at “San Diego’s Fight Against Diabesity” 01/27/11 San Diego
Receptos Cuts Deals With J&J, Lilly 01/06/11 San Diego
FDA Panel Recommends Orexigen’s Obesity Drug, Sequenom Raises Capital, CommNexus Reorganizes Its Free Incubator, & More San Diego Life Sciences News 12/09/10 San Diego
Pearl Therapeutics Beats $3B Lung Drug, Anacor’s Flat IPO, Medtronic Buys Ardian for $800M, & More Bay Area Life Sciences News 12/03/10 San Francisco
Page 1 of 2 next page »